» Articles » PMID: 33352769

Emerging Role and Therapeutic Potential of LncRNAs in Colorectal Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Dec 23
PMID 33352769
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Maintenance of the intestinal epithelium is dependent on the control of stem cell (SC) proliferation and differentiation. The fine regulation of these cellular processes requires a complex dynamic interplay between several signaling pathways, including Wnt, Notch, Hippo, EGF, Ephrin, and BMP/TGF-β. During the initiation and progression of colorectal cancer (CRC), key events, such as oncogenic mutations, influence these signaling pathways, and tilt the homeostatic balance towards proliferation and dedifferentiation. Therapeutic strategies to specifically target these deregulated signaling pathways are of particular interest. However, systemic blocking or activation of these pathways poses major risks for normal stem cell function and tissue homeostasis. Interestingly, long non-coding RNAs (lncRNAs) have recently emerged as potent regulators of key cellular processes often deregulated in cancer. Because of their exceptional tissue and tumor specificity, these regulatory RNAs represent attractive targets for cancer therapy. Here, we discuss how lncRNAs participate in the maintenance of intestinal homeostasis and how they can contribute to the deregulation of each signaling pathway in CRC. Finally, we describe currently available molecular tools to develop lncRNA-targeted cancer therapies.

Citing Articles

LINC01320 facilitates cell proliferation and migration of ovarian cancer via regulating PURB/DDB2/NEDD4L/TGF-β axis.

Wang G, Xu B, Yu X, Liu M, Wu T, Gao W Sci Rep. 2024; 14(1):26233.

PMID: 39482389 PMC: 11527871. DOI: 10.1038/s41598-024-78255-z.


Pan-Cancer Analysis Reveals Long Non-coding RNA (lncRNA) Embryonic Stem Cell-Related Gene (ESRG) as a Promising Diagnostic and Prognostic Biomarker.

Fageer S, Alamin M, Attaelmanan A, Alfaki M Cureus. 2024; 16(8):e67389.

PMID: 39310490 PMC: 11414139. DOI: 10.7759/cureus.67389.


Role of Native Probiotic Lactobacillus Species via TGF-β Signaling Pathway Modulation in CRC.

Sepehr A, Aghamohammad S, Ghanavati R, Talebi M, Pourshafie M, Rohani M Iran Biomed J. 2024; 28(4):168-78.

PMID: 39279541 PMC: 11444483. DOI: 10.61186/ibj.4012.


Linc00239 Facilitates the Progress of Clear Cell Renal Cell Carcinoma via the miR-204-5p/RAB22A Axis.

Cheng C, Lin S, Zhu A, Hong Z, Shi Z, Deng H Mol Biotechnol. 2024; .

PMID: 38850457 DOI: 10.1007/s12033-024-01202-w.


The epigenetic landscape in intestinal stem cells and its deregulation in colorectal cancer.

Larue A, Atlasi Y Stem Cells. 2024; 42(6):509-525.

PMID: 38597726 PMC: 11177158. DOI: 10.1093/stmcls/sxae027.


References
1.
Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N . Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016; 7:13616. PMC: 5150648. DOI: 10.1038/ncomms13616. View

2.
Fischer J, Calabrese P, Miller A, Munoz N, Grady W, Shibata D . Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation. Proc Natl Acad Sci U S A. 2016; 113(43):12192-12197. PMC: 5087053. DOI: 10.1073/pnas.1611980113. View

3.
Ntziachristos P, Lim J, Sage J, Aifantis I . From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell. 2014; 25(3):318-34. PMC: 4040351. DOI: 10.1016/j.ccr.2014.02.018. View

4.
Klingenberg M, Gross M, Goyal A, Polycarpou-Schwarz M, Miersch T, Ernst A . The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling. Hepatology. 2018; 68(5):1817-1832. DOI: 10.1002/hep.30102. View

5.
Vinson K, George D, Fender A, Bertrand F, Sigounas G . The Notch pathway in colorectal cancer. Int J Cancer. 2015; 138(8):1835-42. DOI: 10.1002/ijc.29800. View